Clinical Trial

Home-based Oral Glucose Tolerance Test for Type 1 Diabetes Screening

Recruiting
View on ClinicalTrials.gov →
Summary
This study aims at quantifying the accuracy of a self-administered fingerstick based glucose tolerance test (GTT@Home) respect to the gold-standard in-clinic venous plasma measures during the oral glucose tolerance test (OGTT) across a wide range of glycemic values in people at risk for clinical type 1 diabetes (T1D) (carriers of at least one islet autoantibody) or with new onset Stage 3 T1D within 100 days from the diagnosis.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-26.
Trial Details
NCT Number NCT07155252
Lead Sponsor Yale University
Collaborators: Breakthrough T1D
Conditions Type 1 Diabetes
Enrollment 60 participants
Start Date 2025-08-26
Primary Completion 2027-09 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2026-03-06